| Name | Title | Contact Details |
|---|
Wave Form Systems Inc is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Euro Dental Implant is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
National HME is accredited by HQAA for Hospice Medical Equipment Services, as well as Clinical Respiratory Services. * National HME provides equipment for hospice patients 24/7 at no additional cost to the hospice program. * National HME provides simplified billing allowing your program more time to devote to patient care while reducing the hassle of HME bill reconciliation. Most contracts offered to hospice programs promote all-inclusive packaging with minimal extra charges allowing you the peace of mind that comes with understanding the exact cost for HME. * National HME maintains a minimal amount of warehoused equipment to streamline and work efficiently in our distribution centers. With new contracts equipment will be purchased for your initial deliveries and start up. This will bring a sense of revitalization to your staff and patients, enhancing morale and improving referrals. * Our staff at National HME are specifically trained to understand the process of the hospice industry; including death and dying, dealing with emotional and difficult family situations while showing compassion and empathy. We have extensive competency requirements for every employee that works at National HME. * Training for the family and care givers is extensive including detailed written materials provided. * We utilize modern technology that allows for web based ordering, a paperless delivery system that provides real time delivery and better control of the assets of the company. In the near future, we expect our equipment to have RFID technology that will allow us to find misplaced items in facilities more efficiently.
Pulmonary Solutions is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.